BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 29406237)

  • 21. Dasatinib, large granular lymphocytosis, and pleural effusion: useful or adverse effect?
    Paydas S
    Crit Rev Oncol Hematol; 2014 Feb; 89(2):242-7. PubMed ID: 24210599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pleural effusion in patients with chronic myelogenous leukemia treated with dasatinib after imatinib failure.
    Quintás-Cardama A; Kantarjian H; O'brien S; Borthakur G; Bruzzi J; Munden R; Cortes J
    J Clin Oncol; 2007 Sep; 25(25):3908-14. PubMed ID: 17761974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of pleural effusion with an early molecular response in patients with newly diagnosed chronic-phase chronic myeloid leukemia receiving dasatinib: Results of a D-First study.
    Hagihara M; Iriyama N; Yoshida C; Wakita H; Chiba S; Okamoto S; Kawakami K; Takezako N; Kumagai T; Inokuchi K; Ohyashiki K; Taguchi J; Yano S; Igarashi T; Kouzai Y; Morita S; Sakamoto J; Sakamaki H
    Oncol Rep; 2016 Nov; 36(5):2976-2982. PubMed ID: 27665844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic Pitfalls of Chylothorax After Dasatinib Treatment of Chronic Myeloid Leukemia.
    Kelly RL; Bae JY; D'Annunzio S; Montanari F
    Am J Case Rep; 2022 Nov; 23():e938319. PubMed ID: 36444127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An Analysis of Dasatinib Treatment Patterns in Patients with Chronic Myeloid Leukemia after Experiencing Pleural Effusion during Dasatinib Therapy.
    McBride A; Brokars J; Reddy SR; Chang E; Tarbox MH; LeBlanc TW
    Acta Haematol; 2023; 146(4):259-266. PubMed ID: 37037194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Successful treatment of nilotinib-induced pleural effusion with prednisone.
    Chakraborty K; Bossaer JB; Patel R; Krishnan K
    J Oncol Pharm Pract; 2013 Jun; 19(2):175-7. PubMed ID: 23154573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Dasatinib-related pulmonary adverse events in patients with chronic myeloid leukemia].
    Yang S; Qin YZ; Lai YY; Shi HX; Hou Y; Huang XJ; Jiang Q
    Zhonghua Xue Ye Xue Za Zhi; 2020 Dec; 41(12):1013-1019. PubMed ID: 33445849
    [No Abstract]   [Full Text] [Related]  

  • 28. Incidence, risk factors and management of pleural effusions during dasatinib treatment in unselected elderly patients with chronic myelogenous leukaemia.
    Latagliata R; Breccia M; Fava C; Stagno F; Tiribelli M; Luciano L; Gozzini A; Gugliotta G; Annunziata M; Cavazzini F; Ferrero D; Musto P; Capodanno I; Iurlo A; Visani G; Crugnola M; Calistri E; Castagnetti F; Vigneri P; Alimena G
    Hematol Oncol; 2013 Jun; 31(2):103-9. PubMed ID: 22815278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug-induced chylothorax as a rare pleural complication in dasatinib therapy for chronic myeloid leukaemia.
    Ng IK; Ruparel M; Chan EH; Khoo KL
    J R Coll Physicians Edinb; 2024 Mar; 54(1):44-47. PubMed ID: 38486345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is dasatinib-related pulmonary hypertension a clinical concern?
    Szmit S
    Future Oncol; 2015 Sep; 11(18):2491-4. PubMed ID: 26278893
    [No Abstract]   [Full Text] [Related]  

  • 31. Lung abnormalities after dasatinib treatment for chronic myeloid leukemia: a case series.
    Bergeron A; Réa D; Levy V; Picard C; Meignin V; Tamburini J; Bruzzoni-Giovanelli H; Calvo F; Tazi A; Rousselot P
    Am J Respir Crit Care Med; 2007 Oct; 176(8):814-8. PubMed ID: 17600277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severe dyspnoea in a patient with chronic myelogenous leukaemia on a tyrosine kinase inhibitor.
    Ustun C; Randall N; Podgaetz E; Amin K; Dincer HE
    Thorax; 2015 Jul; 70(7):701-4. PubMed ID: 25935168
    [No Abstract]   [Full Text] [Related]  

  • 33. Development of a human herpesvirus 8-negative effusion-based lymphoma during treatment with dasatinib for chronic myeloid leukemia.
    Suyama T; Hagihara M; Matsui N; Irie R; Osamura Y; Sakai T; Watanabe S; Umemoto S; Miyao N
    J Clin Exp Hematop; 2023 Mar; 63(1):43-48. PubMed ID: 36843069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dasatinib induces severe hemorrhagic colitis in a patient with accelerated phase of chronic myelogenous leukemia.
    Yim E; Choi YG; Nam YJ; Lee J; Kim JA
    Korean J Intern Med; 2018 Mar; 33(2):446-448. PubMed ID: 26961484
    [No Abstract]   [Full Text] [Related]  

  • 35. [Chylothorax Related with Dasatinib in the Treatment of Chronic Myeloid Leukemia: Report of 3 Cases].
    Yang L; Lu N; Jing Y; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1348-1353. PubMed ID: 27784355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dasatinib-induced Nonspecific Interstitial Pneumonia That Developed 7 Years after the Initiation of Dasatinib.
    Takekoshi D; Matsui Y; Akutsu T; Nishioka A; Kiritani A; Okuda K; Watanabe J; Miyagawa H; Utsumi H; Hashimoto M; Wakui H; Minagawa S; Hara H; Numata T; Noda Y; Makishima R; Ikegami M; Kawabata Y; Araya J; Kuwano K
    Intern Med; 2020 Sep; 59(18):2297-2300. PubMed ID: 32536651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Efficacy and Safety of First-Line Dasatinib Therapy and the Relevance of Velocity of BCR-ABL1 Transcript Decline for Achievement of Molecular Responses in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: Report from the Juntendo Yamanashi Cooperative Study Group.
    Takaku T; Iriyama N; Mitsumori T; Sato E; Gotoh A; Kirito K; Noguchi M; Koike M; Sakamoto J; Oba K; Komatsu N
    Oncology; 2018; 94(2):85-91. PubMed ID: 29151104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pleural/pericardic effusions during dasatinib treatment: incidence, management and risk factors associated to their development.
    Breccia M; Alimena G
    Expert Opin Drug Saf; 2010 Sep; 9(5):713-21. PubMed ID: 20722490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical profiles of 7 patients with chronic myelogenous leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia treated with dasatinib].
    Hoshino T; Tahara K; Miyawaki K; Hatsumi N; Takada S; Miyawaki S; Sakura T
    Rinsho Ketsueki; 2010 Mar; 51(3):181-8. PubMed ID: 20379112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pleural-pericardic effusion as uncommon complication in CML patients treated with Imatinib.
    Breccia M; D'Elia GM; D'Andrea M; Latagliata R; Alimena G
    Eur J Haematol; 2005 Jan; 74(1):89-90. PubMed ID: 15613116
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.